Related Experiment Video
Updated: Jul 9, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
Published on: June 26, 2014
Identification of three interferon-inducible cellular enzymes that inhibit the replication of hepatitis C virus
Dong Jiang1, Haitao Guo, Chunxiao Xu
1Drexel Institute for Biotechnology and Virology Research, Department of Microbiology and Immunology, Drexel University College of Medicine, 3805 Old Easton Road, Doylestown, PA 18902, USA.
Abstract:
Hepatitis C virus (HCV) infection is a common cause of chronic hepatitis and is currently treated with alpha interferon (IFN-alpha)-based therapies. However, the underlying mechanism of IFN-alpha therapy remains to be elucidated. To identify the cellular proteins that mediate the antiviral effects of IFN-alpha, we created a HEK293-based cell culture system to inducibly express individual interferon-stimulated genes (ISGs) and determined their antiviral effects against HCV. By screening 29 ISGs that are induced in Huh7 cells by IFN-alpha and/or up-regulated in HCV-infected livers, we discovered that viperin, ISG20, and double-stranded RNA-dependent protein kinase (PKR) noncytolytically inhibited the replication of HCV replicons. Mechanistically, inhibition of HCV replication by ISG20 and PKR depends on their 3'-5' exonuclease and protein kinase activities, respectively. Moreover, our work, for the first time, provides strong evidence suggesting that viperin is a putative radical S-adenosyl-l-methionine (SAM) enzyme. In addition to demonstrating that the antiviral activity of viperin depends on its radical SAM domain, which contains conserved motifs to coordinate [4Fe-4S] cluster and cofactor SAM and is essential for its enzymatic activity, mutagenesis studies also revealed that viperin requires an aromatic amino acid residue at its C terminus for proper antiviral function. Furthermore, although the N-terminal 70 amino acid residues of viperin are not absolutely required, deletion of this region significantly compromises its antiviral activity against HCV. Our findings suggest that viperin represents a novel antiviral pathway that works together with other antiviral proteins, such as ISG20 and PKR, to mediate the IFN response against HCV infection.
Insights
Researchers identified viperin, ISG20, and protein kinase R (PKR) as key proteins inhibiting Hepatitis C virus (HCV) replication. Viperin
Area of Science:
- Virology
- Immunology
- Biochemistry
Background:
- Hepatitis C virus (HCV) infection causes chronic hepatitis, treated with interferon-alpha (IFN-alpha) therapies.
- The precise mechanisms of IFN-alpha's antiviral action against HCV are not fully understood.
- Identifying specific cellular proteins involved in IFN-alpha's antiviral effects is crucial for understanding HCV pathogenesis and treatment.
Purpose of the Study:
- To identify cellular proteins mediating the antiviral effects of IFN-alpha against HCV.
- To elucidate the mechanisms by which these identified proteins inhibit HCV replication.
- To investigate the functional domains and requirements for the antiviral activity of viperin.
Main Methods:
- Established a HEK293-based cell culture system for inducible expression of interferon-stimulated genes (ISGs).
- Screened 29 ISGs for their ability to inhibit HCV replication in cell culture.
- Utilized mutagenesis studies to determine the functional domains and enzymatic requirements of identified antiviral proteins, particularly viperin.
Main Results:
- Viperin, ISG20, and double-stranded RNA-dependent protein kinase (PKR) were found to noncytolytically inhibit HCV replicon replication.
- ISG20's inhibition relies on its 3'-5' exonuclease activity, while PKR's inhibition depends on its protein kinase activity.
- Viperin demonstrated antiviral activity dependent on its radical S-adenosyl-l-methionine (SAM) domain, requiring specific conserved motifs and an aromatic amino acid at its C terminus.
Conclusions:
- Viperin, ISG20, and PKR are key mediators of the IFN-alpha response against HCV infection.
- Viperin functions as a radical SAM enzyme, representing a novel antiviral pathway.
- These findings enhance our understanding of HCV antiviral mechanisms and suggest potential therapeutic targets.
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Hepatitis
Inhibitors Of Virion Release
Inhibitors of Virion Maturation and Assembly
Antiviral Nucleoside Inhibitors
Viruses with RNA Genomes

